Share: Facebook Twitter LinkedIn
Activity Provided By:

i3 Health

Diagnosis and Evidence-Based Management of T-Cell Lymphoma

Access Activity

Overview / Abstract:


T-cell lymphoma (TCL) is an uncommon subtype accounting for approximately 15% of all cases of non-Hodgkin lymphoma in the United States (LRF, 2022). Compared with its B-cell counterpart, TCL has a poor prognosis and is associated with a 5-year survival rate of less than 20%. The clinical and pathologic presentations of TCL are varied and often nonspecific, making diagnosis and treatment challenging (Salem et al, 2021). In this webinar, Aaron Goodman, MD, will update clinicians on evidence-based criteria for differential diagnosis, appraise efficacy and safety data to guide therapeutic selection for newly diagnosed and relapsed/refractory disease, and highlight strategies for optimizing treatment tolerability and improving outcomes in patients with TCL.


Hematology/oncology physicians, nurse practitioners, physician assistants, oncology nurses, and other health care professionals involved in the treatment of patients with T-cell lymphoma (TCL).


Upon completion of this activity, participants should be able to:

- Assess guideline recommendations for the diagnostic workup of TCL
- Evaluate emerging efficacy and safety data on novel therapies for newly diagnosed and relapsed/refractory TCL
- Apply strategies for optimizing the safety and tolerability of novel and established TCL therapies


Jun 29, 2023


Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME


Online, Webinar / Webcast / Video

Credits / Hours




Presenters / Authors / Faculty

Aaron Goodman, MD, UC San Diego Health

Keywords / Search Terms

Oncology, i3 Health, CME, NCPD, free CNE, free NCPD, Free CE, Free CME, Nursing, Oncology Nursing, Physician, T-cell, Lymphoma, T-cell lymphoma, Oncologist

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map